Location · Los Angeles, CA
Clinical trials in Los Angeles, CA
1046 recruiting studies have a site in the Los Angeles area, and 273 of them accept healthy volunteers. The area includes Santa Monica, Beverly Hills, Pasadena, Long Beach, Torrance, Inglewood and nearby cities.
1,046 recruiting studiesSource: ClinicalTrials.gov, refreshed October 28, 2026How we list studies
More recruiting studies (pay not posted)
- Recruiting
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
SetPoint Medical Corporation
- Location
- Irvine, CA + 8 other US sites
- Eligibility basics
- Ages 22–60
- RecruitingPhase 2
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
AstraZeneca
- Location
- Newport Beach, CA + 7 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Donidalorsen Treatment in Children With Hereditary Angioedema
Ionis Pharmaceuticals, Inc.
- Location
- Santa Monica, CA + 7 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 2
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmovant, Inc.
- Location
- Santa Barbara, CA + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Inhibikase Therapeutics
- Location
- Scottsdale, AZ + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFU
Lakewood-Amedex Inc
- Location
- Los Angeles, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma
Aspeya, Inc.
- Location
- Anaheim, CA
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1/Phase 2
FT839 in Autoimmune Diseases
Fate Therapeutics
- Location
- Fullerton, CA
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Vertex Pharmaceuticals Incorporated
- Location
- Duarte, CA + 9 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and…
Novo Nordisk A/S
- Location
- Fairhope, AL + 55 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 1/Phase 2
Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy
CytoAgents, Inc.
- Location
- Orange, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Kaneka Medical America LLC
- Location
- Loma Linda, CA + 9 other US sites
- Eligibility basics
- Up to age 21
- RecruitingPhase 2/Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Merck Sharp & Dohme LLC
- Location
- Los Angeles, CA + 19 other US sites
- Eligibility basics
- Ages 1 mo–17
- RecruitingPhase 2
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Apollo Therapeutics Ltd
- Location
- Birmingham, AL + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Cytokinetics
- Location
- Fairhope, AL + 23 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Harmony Biosciences Management, Inc.
- Location
- Peoria, AZ + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
R1 Therapeutics
- Location
- Huntsville, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Evaluation of Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis
CarthroniX, Inc.
- Location
- Los Angeles, CA
- Eligibility basics
- Ages 40–75
- RecruitingPhase 3
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Harmony Biosciences Management, Inc.
- Location
- Los Angeles, CA + 18 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Phoenix, AZ + 54 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
Relay Therapeutics, Inc.
- Location
- Phoenix, AZ + 21 other US sites
- Eligibility basics
- Ages 2+
- RecruitingPhase 2
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
Pacira Pharmaceuticals, Inc
- Location
- Huntington Beach, CA + 2 other US sites
- Eligibility basics
- Ages 45–80
- RecruitingPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
AstraZeneca
- Location
- Glendale, CA + 5 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
AstraZeneca
- Location
- Athens, AL + 206 other US sites
- Eligibility basics
- Ages 18+